Spexib HCG 150mg Tablets | 100-Count | PALBOCICLIB

🇮🇳 India Warehouse
PALBOCICLIB — 150mg per tablet, 100-count pack.
CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.

Key warning: CBC monitoring mandatory (weekly for first 2 cycles, monthly thereafter). Dose reductions for grade 3/4 neutropenia. QT prolongation risk. CYP3A4 substrate — multiple interactions. Embryofetal toxicity.

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is Spexib HCG 150mg used for?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.”}},{“@type”:”Question”,”name”:”What are the side effects of PALBOCICLIB?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Neutropenia (very common and dose-limiting), fatigue, nausea, infections, mouth sores, diarrhea, alopecia, anemia, thrombocytopenia.”}},{“@type”:”Question”,”name”:”Where does this ship from?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Ships from India Warehouse — international delivery worldwide.”}}]}

What is Spexib HCG 150mg (PALBOCICLIB)?

CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.

How it Works

Inhibits cyclin-dependent kinases 4 and 6 (CDK4/6) — prevents Rb phosphorylation and cell cycle progression from G1 to S phase, halting tumor proliferation.

Quick Specs

Form Oral tablets — pre-dosed
Active Ingredient PALBOCICLIB
Dose per Tablet 150MG
Pack Size 10×10 (100 tablets)
Storage Room temperature (15–25°C), cool dry place
Shelf Life 2–3 years (properly stored)

Common Side Effects

Neutropenia (very common and dose-limiting), fatigue, nausea, infections, mouth sores, diarrhea, alopecia, anemia, thrombocytopenia.

Safety Warnings

⚠️ CBC monitoring mandatory (weekly for first 2 cycles, monthly thereafter). Dose reductions for grade 3/4 neutropenia. QT prolongation risk. CYP3A4 substrate — multiple interactions. Embryofetal toxicity.

🌏 International shipping: 7–14 days

Frequently asked questions

How does my subscription work?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

How do I edit what's in my plan?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Can I change my next delivery date?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

It's been a while since I took the quiz. Can I get a new recommendation?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Spexib HCG 150mg Tablets | 100-Count | PALBOCICLIB”

Your email address will not be published. Required fields are marked *